LOGIMAX

This brand name is authorized in Cyprus, Germany, Spain, Finland, France, Hong Kong, Mexico

Active ingredients

The drug LOGIMAX contains a combination of these active pharmaceutical ingredients (APIs):

1	Felodipine UNII OL961R6O2C - FELODIPINE
	Felodipine is a vascular selective calcium antagonist, which lowers arterial blood pressure by decreasing systemic vascular resistance. Felodipine is effective in all grades of hypertension.
	Read more about Felodipine
2	Metoprolol UNII TH25PD4CCB - METOPROLOL SUCCINATE
	Metoprolol is a cardioselective beta-adrenergic blocking agent. It has a relatively greater blocking effect on beta1-receptors (ie those mediating adrenergic stimulation of heart rate and contractility and release of free fatty acids from fat stores) than on beta2-receptors, which are chiefly involved in broncho and vasodilation.
	Read more about Metoprolol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LOGIMAX Prolonged-release tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07FB02	Metoprolol and felodipine	C Cardiovascular system → C07 Beta blocking agents → C07F Beta blocking agents and other antihypertensives → C07FB Beta blocking agents, selective, and other antihypertensives
Discover more medicines within C07FB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01563509, 06132352, 06132369, 06132375, 06142095, 09944576, 15746886
ES	Centro de información online de medicamentos de la AEMPS	60612
FI	Lääkealan turvallisuus- ja kehittämiskeskus	172627, 439489
FR	Base de données publique des médicaments	61950444
HK	Department of Health Drug Office	38314
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	346M96